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Objective To de®ne: (1) the prevalence of and (2) factors
associated with undertreatment of hypertension in older
persons; and (3) the prevalence of speci®c drug regimens
and reasons for their selection.
Participants Cross-sectional survey of persons aged > 65
years living in Dicomano, Italy.
Main outcome measures Prevalence of untreated and
uncontrolled hypertension, both de®ned on the basis of
two blood pressure (BP) cut-off points (> 140/90 and
> 160/90 mmHg) and of the presence of pharmacological
treatment. Predictors of undertreatment were analysed for
the higher BP cut-off only.
Results Five hundred of 692 (72.3%) and 380/692 (54.9%)
participants met the 140/90 and the 160/90 mmHg BP
criterion, respectively. Of the latter, 162 (42.6%) were
untreated, 119 (31.3%) had uncontrolled and 99 (26.1%)
controlled hypertension. Women [odds ratio (OR), 0.4; 95%
con®dence interval (CI), 0.2±0.7], participants with
coronary artery disease (CAD) (OR, 0.2; 95% CI, 0.1±0.6),
stroke (OR, 0.3; 95% CI, 0.1±0.7), and preserved cognitive
status (Mini Mental State Examination score > 21: 0.3; 95%
CI, 0.2±0.7) were more frequently treated. Uncontrolled
hypertension was less likely in women (OR, 0.5; 95% CI,
0.3±1.0) and CAD patients (OR, 0.3; 95% CI, 0.1±0.7).
Angiotensin converting enzyme (ACE)-inhibitors (55%),
calcium (Ca)-antagonists (31%) and diuretics (20%) were
the drugs most commonly prescribed. ACE-inhibitors were
preferred, and diuretics rarely used, in diabetic subjects.
Ca-antagonists were used mostly in CAD participants.
Conclusions Hypertension is undertreated in the majority
of noninstitutionalized older adults, especially in men with
impaired cognition and no vascular disease. Drug
regimens are mostly based on ACE-inhibitors and Ca-
antagonists, as a result of associated clinical conditions,
requiring individualized treatment. J Hypertens 1999,
17:1633±1640 & Lippincott Williams & Wilkins.
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Introduction
Since the publication of the results of the European
Working Party on Hypertension in the Elderly Pro-
gram [1] in 1985, evidence on the bene®ts of drug
treatment of hypertension in older persons has been
consistently accumulating. Randomized clinical trials
[2±4] showed that diuretics and â-blockers, used as
®rst-line antihypertensive medications, reduce the in-
cidence of all-cause and coronary death, stroke, myo-
cardial infarction, and congestive heart failure in the
elderly. According to a recent meta-analysis [5], the
advantage of treatment is greater in older than in
younger patients. More recently, nitrendipine was also
shown to reduce the incidence of stroke, of all cardio-
vascular events [6] and, possibly, of dementia [7] in
older participants in the Systolic Hypertension in
Europe (Syst-Eur) trial.
At a population level, mortality and morbidity due to
hypertension can be reduced only if evidence-based
guidelines are thoroughly and appropriately followed in
community medicine. Unfortunately, hypertension still
remains largely undiagnosed or untreated, at any age
[8] but more frequently in older adults [8,9]. Moreover,
the therapeutic regimens usually prescribed are rarely
based on diuretics and â-blockers, the only drugs
proven effective in the prevention of hypertension-
related complications [10] until the recent publication
of the Syst-Eur [6] and the Captopril Prevention
Project (CAPPP) [11] studies.
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Identi®cation of factors associated with undertreatment
of hypertension may have major public health impact,
providing clues to improve the delivery of effective
care and, ultimately, to reduce the burden of the
disease in the general population. In countries such as
the USA, where universal health care coverage is
lacking, the strongest barriers to appropriate treatment
are the limited access to health services and the
excessive costs of care [12], but it is unlikely that these
®ndings can be generalized to countries with different
health care systems. Furthermore, other unidenti®ed
factors may play a role, since suboptimal blood pressure
control has been reported even among patients who
receive regular care [9,13,14].
Therefore, we carried out the present study to de®ne
the prevalence of, and factors associated with, under-
treatment of older hypertensive persons living in a
small town near Florence, Italy; a country where the
National Health Service warrants free access to health
care and availability of drugs. As a secondary objective,
we aimed at identifying speci®c patterns of treatment,
and at verifying whether associated comorbidities,
which might require individualized treatment, can
explain the choice, by the primary care physicians
(PCP), of a therapeutic regimen not based on diuretics
and â-blockers. When the data for this study were
collected in 1995, the Joint National Committee V
(JNC-V) guidelines [10] strongly recommended these
drugs as ®rst-line antihypertensive agents, which were
also listed ®rst, in terms of proven bene®ts from
mortality-morbidity studies, in the 1993 World Health
Organization (WHO)/International Society of Hyper-
tension (ISH) guidelines [15].
Methods
Population and protocol of the study
This analysis was carried out using data from a popula-
tion-based survey on heart failure, enrolling the entire
noninstitutionalized, community-dwelling older popula-
tion living in Dicomano, a small town near Florence,
Italy (`Insuf®cienza Cardiaca negli Anziani Residenti a
Dicomano', ICARe Dicomano Study) in April 1995.
The general design of the survey has been previously
published in detail [16]. Brie¯y, all community-dwell-
ing citizens aged > 65 years recorded in the City
Registry Of®ce were considered eligible for multidi-
mensional, geriatric assessment consisting of home
interview, laboratory testing and clinical examination.
Proxy interviews were obtained in 29 cases with severe
cognitive or sensorial impairment. Further clinical in-
formation was gathered from the participants' PCP,
who answered a structured questionnaire on history and
treatment of several clinical conditions, including
hypertension.
Data collection
Blood pressure measurement and diagnosis of
hypertension
Blood pressure (BP) was measured by the study physi-
cians, with the participant in the supine position after a
10-min rest, using a cuff of proper size for arm
circumference. A ®rst measure was taken at each arm.
Two further readings were thereafter obtained 1±2 min
apart, usually at the nondominant arm, except when
systolic BP (SBP) differed between the two sides by
more than 10 mmHg. In these cases, the side with the
highest SBP was chosen. Diastolic BP (DBP) was taken
at Korotkoff's phase V. The second and third measures
at the selected arm were averaged and mean values
were considered as the reference SBP and DBP,
respectively.
For descriptive purposes, the prevalence of hyper-
tension was ®rst de®ned, following commonly accepted
criteria, for SBP > 140 mmHg or DBP > 90 mmHg, or
current treatment with antihypertensive drugs, as
defined later. However, a higher SBP cut-off
(> 160 mmHg) was considered more appropriate for
the analysis of predictors of undertreatment, since this
could minimize the number of subjects falsely de®ned
as uncontrolled hypertensive on the basis of a single set
of measures. Indeed, according to both the JNC V [10]
and WHO/ISH [15] guidelines, persistently elevated
BP values must be veri®ed, and nonpharmacological
interventions ®rst attempted, before a drug treatment is
started. Moreover, in 1993, BP values , 160=90 mmHg
were suggested as a therapeutic goal for older adults
[10].
Participants with hypertension, diagnosed according to
either threshold, were further classi®ed as: (1) con-
trolled (BP below the diagnostic threshold); (2) uncon-
trolled (current antihypertensive treatment but BP
above the diagnostic threshold); or (3) untreated (no
drug therapy).
Drug history
Medications were investigated with the drug inventory
method [17] and recorded using a commercially or-
iented Italian coding system. Drugs were therefore
classi®ed with the international ATC coding [18], a
hierarchical classi®cation system grouping pharmaco-
logical agents on the basis of their main anatomic (A)
site of action, and therapeutic (T) and chemical (C)
characteristics. The following ATC codes were consid-
ered to represent antihypertensive drugs: C02 (central
antiadrenergics), C03A, C03B, C03EA (low-ceiling
diuretics, i.e. thiazides and thiazide-like), C07 (â-block-
ers), C08 [calcium (Ca)-antagonists], and C09 [angio-
tensin converting enzyme (ACE)-inhibitors]. Many of
these drugs can be prescribed for the treatment of
diverse clinical conditions. Hence, in case of uncertain
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or possibly multiple indications, coding for antihyper-
tensive treatment was de®nitely assigned only when
antihypertensive prescription had been reported in the
PCP's questionnaire.
Predictors of undertreatment and of speci®c therapeutic
regimens
Several variables exploring the traditional areas of
multidimensional geriatric assessment [19] (socio-eco-
nomic status, physical health, comorbidity and func-
tioning, cognition and mood) were considered to be
potentially associated with untreated or uncontrolled
hypertension.
Socio-economic variables included marital status,
household composition, years of formal education, pre-
vious occupation, and indirect indicators of poor eco-
nomic status (self-rated inadequate income and need
for regular economic help). Comorbidity was diagnosed
from standardized algorithms [16], based on history,
physical, laboratory, and instrumental ®ndings directly
collected by the study physicians. Diseases assumed to
have a potential association (positive or negative) with
undertreatment of hypertension were: diabetes (in-
creased fasting glucose, treatment with antidiabetic
agents or, in case of uncertainty, increased HbA1c),
heart failure (McKee's criteria [20]), coronary heart
disease (myocardial infarction or angina pectoris, based
on ECG, history and Rose's Questionnaire [21]), pre-
vious stroke, and indicators of alcohol abuse (positive
CAGE questionnaire [22] or associated increase in
mean corpuscolar volume and ã-glutamil-transpeptidase
[23]). The total number of chronic conditions (includ-
ing vascular disease such as coronary heart disease,
stroke or lower extremity arterial disease, diabetes,
heart failure, asthma or chronic bronchitis, chronic liver
disease or peptic ulcer) was also taken into account.
Disability (need for someone's help in one or more
basic activity of daily living±BADL) was evaluated
with a modi®ed WHO scale [24,25]. Cognitive impair-
ment, depressive or anxiety symptoms were screened
with the Mini Mental State Examination (MMSE)
[26], the Geriatric Depression Scale [27] and a brief
version of the Hopkins' Symptoms Check List (HSCL)
[28,29], respectively. The body mass index was calcu-
lated as body weight (kg) divided by height squared
(m2).
Age, gender and history of diabetes, coronary artery
disease, and heart failure were considered as possible
predictors of speci®c therapeutic regimens.
Analytic procedure
Statistical analysis was carried out using the SPSS for
Windows 8.0 package. Mean values are expressed as
mean SEM. The ÷2 test and the Student's t test were
used to compare relative frequencies and mean values,
respectively.
Continuous variables were dichotomized using standard
cut-off points whenever possible or, otherwise, contrast-
ing one extreme of the population distribution (10th or
90th percentile) to the remaining population. Selection
between the 10th and the 90th percentile was sup-
ported by the clinical signi®cance of each variable as a
potential risk factor for undertreatment. Hence, the
MMSE score, which decreases with cognitive impair-
ment, and the HSCL score, which increases with
anxiety symptoms, were dichotomized at 21 (10th
percentile) and at 1.5 (90th percentile), respectively.
From bivariate comparisons, candidate predictors
(P , 0:1) of treated hypertension and controlled hyper-
tension were selected and entered into separate logistic
regression analysis models, to identify the explanatory
variables of each individual outcome. Logistic regres-
sion was also used to identify the independent predic-
tors of speci®c drug regimens (ACE-inhibitors, Ca-
antagonists, and diuretics).
P , 0:05 was considered statistically signi®cant.
Results
Complete data were available for 692 out of 864
eligible subjects (80.0%). Of the 172 subjects not
included, four had died before study onset, 163 refused
to participate, and ®ve had missing data. The propor-
tion of men was slightly, but signi®cantly, higher
among nonparticipants (23.1%) than participants
(17.5%; P  0:040), whereas mean age was comparable
(74:2 0:6 years versus 74:1 0:3 years, respectively;
P  0:906). According to the PCPs' reports, the fre-
quency of hypertension was similar between partici-
pants and nonparticipants (35.5 versus 37.2%;
P  0:607).
Prevalence, treatment and control of hypertension
Table 1 shows the prevalence of hypertension accord-
ing to the 140=90 and 160=90 mmHg cut-off, in relation
to treatment and BP control. According to the
140=90 mmHg cut-off, the prevalence of hypertension
was 72.3% (500=692). When the more restrictive criter-
ion of 160=90 mmHg was considered, 380 participants
(54.9%) were de®nitely hypertensive, of whom 281
were untreated or uncontrolled (Table 1). Therefore,
the prevalence of de®nitively undertreated hyper-
tension in the study population was 40.6% (281 of 692),
within a 95% con®dence interval (CI) of 36.9±44.3%.
Of the 162 cases with untreated hypertension, only 19
(11.7%) had an antihypertensive medication prescribed
by their PCP and can therefore be considered as totally
noncompliant, whereas the remaining 143 had not been
prescribed antihypertensive drugs.
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Predictors of undertreated hypertension
Bivariate predictors of undertreated, either untreated
or uncontrolled, hypertension (> 160=90 mmHg cut-
off) are reported in Table 2, whereas Figures 1 and
2 show the logistic models for multivariate prediction
of the two outcomes. Women and participants with
associated coronary artery disease, stroke or preserved
cognitive status were less likely to be untreated,
both in bivariate (Table 2) and in multivariate (Fig.
1) analyses. A bivariate association with current or
previous smoking status (Table 2) was not con®rmed
in the multivariate model (Fig. 1). Among cognitively
impaired (MMSE < 21) participants, the presence of
a caregiver was not predictive of drug treatment
(data not shown). Uncontrolled hypertension was
negatively associated with female gender and coexist-
ing coronary artery disease, in both bivariate (Table
2) and multivariate (Fig. 2) comparisons. A border-
line association with a lower education (Table 2) was
not con®rmed in the logistic regression model (Fig.
2).
The three largest PCP practices in Dicomano included
about 92% of the study population. The prevalence of
treated and controlled hypertension was comparable
among the three PCP practices (data not shown).
Table 1 Prevalence of untreated, uncontrolled, and controlled hypertension (HT) by gender, according to two different blood pressure cut-
off points
Men Women Total
n % of HT
% of
population n % of HT
% of
population n % of HT
% of
population
> 140=90 mmHg cut-off
Normotensive 93 ± 32.5 99 ± 24.4 192 ± 27.7
Untreated HT 124 64.2 158 51.5 282 56.4
Uncontrolled HT 60 31.3  67.5 117 38.1  75.6 177 35.4  72.3
Controlled HT 9 4.7 32 10.4 41 8.2
Total 286 100 100 406 100 100 692 100 100
> 160=90 mmHg cut-off
Normotensive 137 ± 47.9 175 ± 43.1 312 ± 45.1
Untreated HT 80 53.7 82 35.5 162 42.6
Uncontrolled HT 45 30.2  52.1 74 32.0  56.9 119 31.3  54.9
Controlled HT 24 16.1 75 32.5 99 26.1
Total 286 100 100 406 100 100 692 100 100
Percentages do not sum up to 100 due to rounding.
Table 2 Bivariate predictors of untreated and uncontrolled hypertension (HT)
(> 160/90 mmHg cut-off)
Untreated HT (n  380) Uncontrolled HT (n  218)
Factor OR (95% CI) P OR (95% CI) P
Demographic and social variables
Age > 75 years 1.4 (1.0±2.2) 0.087 0.8 (0.5±1.4) 0.464
Female sex 0.5 (0.3±0.7) 0.000 0.5 (0.3±0.9) 0.032
Being married 0.9 (0.6±1.4) 0.762 1.0 (0.6±1.8) 0.916
Education . 6 years 1.1 (0.5±2.2) 0.817 2.7 (0.9±7.9) 0.054
Poor economic status 1.2 (0.7±2.0) 0.523 1.0 (0.5±2.1) 0.990
Living alone 0.7 (0.4±1.2) 0.214 0.8 (0.4±1.6) 0.615
Health status
Current or ex-smoking 1.6 (1.4±2.4) 0.033 1.6 (0.9±2.8) 0.115
BMI > 30 kg=m2 0.7 (0.4±1.2) 0.194 0.9 (0.5±1.7) 0.819
Alcohol abuse 1.6 (0.8±3.2) 0.185 1.2 (0.4±3.4) 0.688
Heart failure 0.7 (0.4±1.2) 0.163 0.6 (0.4±1.3) 0.234
Diabetes 0.7 (0.4±1.2) 0.192 0.8 (0.3±1.5) 0.435
Coronary artery disease 0.3 (0.1±0.7) 0.007 0.4 (0.1±0.9) 0.017
Stroke 0.3 (0.1±0.9) 0.022 1.2 (0.5±3.2) 0.431
> 2 chronic diseases 1.4 (0.9±2.2) 0.114 1.1 (0.6±1.9) 0.806
Disability in > 1 BADL 1.5 (0.7±3.4) 0.327 2.6 (0.7±9.9) 0.144
Cognition and mood
MMSE . 21 0.4 (0.2±0.7) 0.003 0.5 (0.2±1.4) 0.205
GDS > 14 0.9 (0.6±1.4) 0.593 0.7 (0.4±1.2) 0.155
HSCL . 1:5 1.0 (0.6±1.5) 0.858 1.2 (0.7±2.3) 0.520
OR, odds ratio; CI, con®dence interval; BMI, body mass index; BADL, basic activities of daily living; MMSE, Mini
Mental State Examination; GDS, Geriatric Depression Scale; HSCL, Hopkins' Symptoms Check List.
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Drug regimens
The majority (79.9%) of the 218 treated hypertensive
participants was on monotherapy. The most frequently
prescribed antihypertensive agents were ACE-inhibi-
tors (119 of 218, 54.6%), followed by Ca-antagonists (71
of 218, 32.6%), low-ceiling diuretics (41=218, 18.8%),
central antiadrenergics (18 of 218, 8.3%), and â-blockers
(15=218, 6.9%). Age, gender and history of diabetes,
coronary artery disease, and heart failure were entered
into three separate logistic regression models, testing
for their multivariate association with ACE-inhibitors,
Ca-antagonists, and low-ceiling diuretics, respectively
(Fig. 3). History of diabetes tended to be associated
positively with the prescription of ACE-inhibitors and
negatively with the use of diuretics, whereas male
gender and history of coronary artery disease indepen-
dently predicted the use of Ca-antagonists (Fig. 3). No
therapeutic regimen was signi®cantly associated with a
higher prevalence of `acceptably' (, 160=90 mmHg
cut-off) controlled hypertension (data not shown).
Discussion
In the present study, we assessed the prevalence and
found some predictors of de®nitely undertreated hyper-
tension in the elderly. Major strengths of this study are
the evaluation of an entire community of free-living
individuals, the accurate collection of medication use,
validated with information obtained from the PCP, and
the direct assessment of several possible predictors of
undertreatment. Since an individual's BP is evaluated
more accurately when several measures are taken on
different occasions, a possible limitation of the study is
that BP was measured in a single occasion, although
averaging two out of three readings. Within-person
variability of BP measures, which is common, especially
at an advanced age, was shown to affect substantially
the estimated prevalence of undertreated hypertension
in a previous study [30]. However, even a single BP
measure accurately predicts clinical events [31±33].
Furthermore, Mancia et al. have recently shown that
clinic uncontrolled BP is highly predictive of exceed-
ingly elevated average home and 24-h BP [34].
The prevalence of hypertension in the elderly popula-
tion of Dicomano was higher than in previous Italian
series [35]. In particular, the Italian Longitudinal Study
on Aging, using BP cut-off values of 140=90 mmHg,
found a 67.3 and 59.4% prevalence in women and men,
out of a random sample of 5632 subjects aged 65±84
years [36]. A possible source of variation, in the com-
parison between this and previous studies, is that BP
was measured in the supine position. Measures of BP
in the supine position have been used both in observa-
tional studies [37] and in randomized clinical trials [3],
although the sitting position is usually considered as
the acknowledged standard [10,15]. However, we argue
that this methodological difference should have only a
Untreated HT
Less likely More likely
Age ($ 75 versus
65–74 years)
Gender
(F versus M)
Smoking
(yes versus no)
CAD
(yes versus no)
Stroke
(yes versus no)
MMSE
 (. 21 versus # 21)
â coefficient 23 22 21 0 1
OR 0.05 0.1 0.4 1 2.7
Fig. 1
Logistic regression model of factors associated with untreated
hypertension in 380 community-dwelling hypertensive elderly. The 95%
con®dence interval around the estimate is shown. HT, hypertension; F,
female; M, male; CAD, coronary artery disease; MMSE, Mini Mental
State Examination; OR, odds ratio.
Uncontrolled ( BP $ 160/90 mmHg) HT
Less likely More likely
Age ($ 75 versus
 65–74 years)
Gender
(F versus M)
Education
(. 6 versus # 6 years)
CAD
(yes versus no)
â coefficient 23 22 21 0 1
OR 0.05 0.1 0.4 1 2.7
2 3
7.4 20.1
Fig. 2
Logistic regression model of factors associated with uncontrolled
hypertension in 218 community-dwelling treated hypertensive elderly.
The 95% con®dence interval around the estimate is shown. BP, Blood
Pressure; HT, hypertension; F, female; M, male; CAD, coronary artery
disease; OR, odds ratio.
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minor impact in surveys of elderly subjects, since the
difference between supine and sitting BP has been
shown to be not signi®cant for SBP in a broad age
range, and trivial for DBP at an advanced age [38]. We
therefore believe that our ®gures truly re¯ect an
exceeding prevalence of hypertension in our study
population.
In Italy, the National Health Service warrants each
elderly citizen a PCP and a full availability of drugs,
with, at most, a minor copayment. In spite of these
favorable premises, control of hypertension in our study
was far from optimal. Indeed, taking into account the
160=90 mmHg cut-off as a reasonable therapeutic goal
for older adults, only 26% of hypertensive participants
were acceptably treated, and most were totally undiag-
nosed and/or untreated. These ®gures are within the
broad range observed in other countries with a govern-
ment-®nanced primary health care [37,39±41]. In parti-
cular, Bursztyn et al. [40] reported that 86% out of 448
70-year-old hypertensive citizens of Jerusalem, Israel,
were treated, and 43% had BP values below
160=95 mmHg. Conversely, in a large national random
sample in Canada [41], only 16% of hypertensive
women, and 13% of men aged 65±74 years had their
BP below 140=90 mmHg, whereas an additional 38 and
27%, respectively, were treated but not optimally con-
trolled.
Dicomano is a rural town, whose elderly population has a
low level of formal education (. 6 years in only 9.5% of
cases). Moreover, many persons live in country houses,
isolated and far from the centre of the town [16]. This
may represent a non®nancial barrier in the access to
primary care. Therefore, we acknowledge that our results
possibly depict a worse-case scenario of the prevalence
of undertreated hypertension, rather than a nation-wide
representative picture of the Italian elderly population.
Even with these limitations in mind, these are the only
data available to estimate the need for the prevention of
hypertension-related complications in our country, since
to our knowledge no other recent population-based
survey reported the prevalence of undertreated hyper-
tension in older Italians. If the overall 40.6% (95% CI,
36.9±44.3%) proportion of undertreated hypertension in
Dicomano is projected to the 1991 national population
[42], more than 3.4 million unselected Italians > 65 years
of age can be estimated to be affected (95% CI, 3.1±3.7
million). Finally, it can be calculated that 16%, or about
16 000 cases, of the ®rst-ever strokes annually occurring
in aged Italians (population attributable risk) could be
prevented with appropriate treatment of hypertension
(see Appendix for calculations).
Other ®ndings of this study deserve comment. Unlike
previous investigations [12], a more advanced age was
not an independent risk factor for undertreatment,
ACE-inhibitors Ca-antagonists Diuretics
Less likely More likely
Age ($ 75 versus
 65–74 years)
Gender
(F versus M)
CHF
(yes versus no)
CAD
(yes versus no)
â coefficient 21 0 1
OR 0.4 1 2.7
2
7.4
Diabetes
(yes versus no)
22 21 0 1
0.1 0.4 1 2.7
2 3
7.4 20.1
Less likely More likely
23 22 21 0 1
0.05 0.1 0.4 1 2.7
2
7.4
Less likely More likely
Prescription of:
Fig. 3
Logistic regression models of factors associated with use of angiotensin converting enzyme (ACE)-inhibitors, calcium (Ca)-antagonists, and low-
ceiling diuretics in 218 community-dwelling treated hypertensive elderly. The 95% con®dence interval around the estimate is shown. F, Female; M,
male; CHF, congestive heart failure; CAD, coronary artery disease; OR, odds ratio.
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which, conversely, appeared to be de®nitely more
frequent in men. The more favourable control of BP in
women, also observed by other authors [12,30,41],
probably re¯ects a more health-oriented behaviour in
the female gender. Alcohol abuse and smoking habits
were not signi®cant confounders of this association.
Diagnosis of coronary artery disease was a strong pre-
dictor of more satisfactory control of hypertension, even
after adjusting for gender. Many drugs used for the
treatment of hypertension are also prescribed as anti-
anginal agents, and in epidemiological studies this might
determine a spurious association between the diagnoses
of hypertension and coronary artery disease, based on
drug history. However, such a misclassi®cation bias in
our study is unlikely. Indeed, the presence of antihyper-
tensive drugs was coded by taking into account the
information provided by the PCP on the indications to
treatment, while the diagnosis of coronary artery disease
was based on clinical data independently collected by
the study physicians. Confounding by left ventricular
systolic dysfunction, as a cause of reduced BP values in
formerly hypertensive subjects, is similarly unlikely,
since no association was observed with the clinical
diagnosis of heart failure. Therefore, we believe that the
association between coronary artery disease and a better
control of hypertension in our study truly re¯ects a
higher level of medical attention, more frequent con-
tacts with the PCP, and/or a better compliance with
treatment in patients with heart disease. This interpre-
tation is further supported by the negative association
between untreated hypertension and stroke (Fig. 1), and
by similar results reported by other authors [12]. This
suggests that community medicine is still poorly or-
iented to treat individuals at risk before complications
of hypertension have become clinically evident.
In this study, as in other populations [12], a poor
cognitive status was strongly predictive of untreated
hypertension. PCPs must be aware of the increased risk
of undertreatment of their older patients with initial
cognitive impairment, which can produce a vicious
circle. Hypertension is in fact emerging as a risk factor
for dementia [43], and antihypertensive treatment may
probably reduce the rate of cognitive decline [7].
The more commonly prescribed antihypertensive drugs
were ACE-inhibitors and Ca-antagonists. Our ®ndings
in this small population re¯ect changes in prescribing
patterns [44], and major market shifts [45], which have
been observed on a larger scale. Before the recent
publication of the Syst-Eur [6] and the CAPPP [11]
studies, diuretics and, although with some controversies
[46], â-blockers were the only antihypertensive agents
with de®nitively proven bene®ts on clinical outcomes
[5], and they are the most largely prescribed antihyper-
tensive drugs in England [39]. Thus, the appropriate-
ness of diverging therapeutic attitudes in the medical
community has been challenged [45]. Our results sug-
gest that associated comorbidities could at least in part
explain the choice of therapeutic regimens not based
on these drugs. Indeed, ACE-inhibitors were clearly
preferred, and diuretics avoided, in diabetic subjects,
whereas the use of Ca-antagonists was strongly asso-
ciated with a diagnosis of coronary artery disease. How-
ever, we cannot exclude that previous standard
approaches had been unsuccessfully attempted.
In conclusion, this study con®rms that in older persons,
hypertension is largely undertreated even in a country,
such as Italy, with universal health care coverage. Some
risk factors for undertreatment can be identi®ed.
Among those, cognitive impairment is noteworthy,
since uncontrolled hypertension may accelerate cogni-
tive decline in at-risk individuals. The public health
implications of these ®ndings are remarkable. Know-
ledge of risk factors for undertreatment of hypertension
may provide clues to improve the delivery of ef®cacious
therapies to older populations, and ultimately to de-
crease the burden of mortality, morbidity, and disability
that is associated with this common, treatable condi-
tion.
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Appendix
The population attributable risk (PAR) can be calcu-
lated from Levin's formula [47]:
PAR  p(r ÿ 1)=[ p(r ÿ 1) 1]
where p is the prevalence of the condition in the
population and r is the relative risk or odds ratio. From
the present study, the point estimate for the prevalence
of uncontrolled hypertension is 40.6%. Untreated
hypertensive subjects are comparable with participants
assigned to placebo in randomized clinical trials of
antihypertensive treatment. The relative risk of stroke
in patients receiving low-dose diuretic, as compared
with placebo, is 0.66 [5]. Thus, PAR for stroke in
subjects with uncontrolled hypertension is 16.0%.
The annual incidence of ®rst-ever stroke in commu-
nity-dwelling Italians aged 65 years and over can be
calculated from two population-based surveys, which
reported 372 of 34 300 [48] and 690 of 55 079 [49]
(average, 1.19%) cases of stroke per year in this age
range. When referred to the 1991 national population
65 years of age and older (8.4 million) [42], this means
100 295 cases of stroke per year. Thus, the number of
strokes which might be prevented each year with better
hypertension control in the elderly population is:
100 295 3 16:0%  16 047.
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